1. Pink Sheet
  2. >>Pathways & Standards
  3. >>Review Pathways

PDUFA Workload Sets Records, But Inflation Generates More Revenue

 
• By Derrick Gingery

The PDUFA revenue inflation adjustment was higher than the workload adjustment for the first time in seven years.

White round tablets lie in front of President Franklin, who is depicted on a hundred-dollar bill. The concept of the high cost of medicine, pharmaceuticals. - Image
The workload and inflation adjustment formulas affect the PDUFA revenue target, which is used to set individual user fees. • Source: Shutterstock

Despite another year with record workload levels, the US Food and Drug Administration's prescription drug user fee program revenue was actually more affected by inflation.

For the first time in seven years, the FDA's inflation formula added more money to the prescription drug user fee...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Review Pathways

More from Pathways & Standards

Generic Drug Office’s Policy Staff Returning To US FDA

 
• By Derrick Gingery

The group had been laid off as part of the 1 April reduction-in-force, which led to missed guidance publication deadlines.

Nipah Vaccine With ‘Pandemic Potential’ Wins EMA PRIME Designation

 
• By Neena Brizmohun

The developers of the ChAdOx1 NipahB vaccine will be able to benefit from the early and enhanced support that the European Medicines Agency offers through its priority medicines scheme.

Elegy For SACHRP: US HHS Research Protection Panel Tackled Tough Pediatric Trial Questions

 
• By Bridget Silverman

The termination of the HHS Secretary’s Committee on Human Research Protections closed an important forum for discussing pediatrics and pregnancy in clinical trial design, a former SACHRP chair said.